Is aminophylline useful in chronic obstructive pulmonary disease? when should corticosteroids be used?
Figueroa Lebrón, R.
Boletin de la Asociacion Medica de Puerto Rico 80(9): 340
1988
ISSN/ISBN: 0004-4849 PMID: 3190844 Document Number: 700144
Document emailed within 1 workday
Related Documents
Sherter, C.B. 1983: The use of corticosteroids in asthma, bronchitis and chronic obstructive pulmonary disease Connecticut Medicine 47(7): 389-392Barbas Filho, J.V.; Barbas, C.S.; de Carvalho, C.R.; Godoy, R.; Vianna, E.dos.S.; Lorenzi Filho, G. 1991: Response to the administration of corticosteroids in patients with chronic obstructive lung disease and asthma Revista do Hospital das Clinicas 46(4): 159-162
Goel, A.; Suri, J.C.; Aggarwal, K. 1992: Role of corticosteroids in the management of chronic obstructive lung disease: factors predicting response Indian Journal of Chest Diseases and Allied Sciences 34(1): 11-17
Xu, Y.J.; Zhang, Z.X.; Duan, S.F. 1991: Pulmonary artery compliance and its relation with pulmonary hemodynamics in patients with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 30(3): 138-140; 187
Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Sarac, R.; Cikes, I.; Butković, D.; Dimov-Butković, D. 1995: Doppler echocardiography in the evaluation of pulmonary hypertension in chronic obstructive pulmonary disease Lijecnicki Vjesnik 117(1-2): 9-15
Rahimi-Rad, M.Hossein.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Rahimi-Rad, M.H.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Cousineau, G.; Leveillé, P.; Lemire, P. 1983: Radiologic aspects of pulmonary edema in chronic obstructive pulmonary disease L'Union Medicale du Canada 112(1): 45-48
Incorvaia, C.; Russo, A.; Foresi, A.; Berra, D.; Elia, R.; Passalacqua, G.; Riario-Sforza, G.G.; Ridolo, E. 2014: Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study European Journal of Physical and Rehabilitation Medicine 50(4): 419-426
Deepak, T.H.; Mohapatra, P.R.; Janmeja, A.K.; Sood, P.; Gupta, M. 2014: Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease Indian Journal of Chest Diseases and Allied Sciences 56(1): 7-12
Kirisawa, T. 1979: Studies on chronic obstructive pulmonary disease by selective alveolo-bronchography (SAB). Pulmonary emphysema lesions Nihon Kyobu Shikkan Gakkai Zasshi 17(4): 212-221
Kasibowska-Kuźniar, K.; Jankowska, R.; Kuźniar, T. 2007: Quality of life outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Wiadomosci Lekarskie 60(3-4): 158-161
Ouksel, H.; Pison, C. 2004: Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease La Revue du Praticien 54(13): 1432-1435
Nici, L.; Lareau, S.; ZuWallack, R. 2010: Pulmonary rehabilitation in the treatment of chronic obstructive pulmonary disease American Family Physician 82(6): 655-660
Marchman, H.B.; Skolnick, J.L. 1992: Blood pressure changes in patients with chronic obstructive pulmonary disease and hypertension completing phase II pulmonary rehabilitation Journal of the Kentucky Medical Association 90(10): 503-505
Wan, P.; Zhong, X.-n.; He, Z.-y.; Zhang, J.-q.; Liu, G.-n.; Lao, Q.-f. 2009: The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 48(10): 841-845
Titova, O.N.; Ignat'ev, V.A.; Didur, M.D.; Kameneva, M.Iu.; Sukhovskaia, O.A. 2008: Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 80(3): 28-33
Lampert, E.; Tuo, N.; Frans, A.; Lonsdorfer, J. 1991: Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment Pathologie-Biologie 39(1): 29-33